-
Mashup Score: 0Panel outlines ACR Workforce Solutions Committee initiatives - ACR Convergence Today - 1 year(s) ago
The Association of American Medical Colleges estimates a shortage of as many as 139,000 physicians by 2033. ACR Workforce Solutions Committee Chair Daniel Battafarano, DO, outlined the types of projects committee members will undertake to improve the practice of rheumatology for providers and patients and combat the workforce shortage.
Source: ACR Convergence TodayCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 4Social media can facilitate connections and collaboration to advance rheumatology - ACR Convergence Today - 1 year(s) ago
At events like ACR Convergence, social media helps enhance engagement among attendees. It also can be used to amplify one’s own work and as a research tool. Jean Liew, MD, MS, shared her expertise with social media and how the COVID-19 Global Rheumatology Alliance used it to benefit the field.
Source: ACR Convergence TodayCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Physician business owners discuss direct care models and their future in rheumatology - ACR Convergence Today - 1 year(s) ago
Direct care, concierge medicine, wellness, and coaching models are changing the ways rheumatologists practice and patients experience care. Diana Girnita, MD, PhD, discussed the potential of direct care and addressed some of the common fears providers have related to this approach to serving patients.
Source: ACR Convergence TodayCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0ACR advocacy outlines legislative priorities, how members can get involved - ACR Convergence Today - 1 year(s) ago
The ACR Government Affairs Committee (GAC) and the political action committee, RheumPAC, promote legislation that allows clinicians to stay focused on patient care. GAC Chair Blair Solow, MD, MSc, explained the committee’s current priorities.
Source: ACR Convergence TodayCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1Experts share best practices and recent insights to improve care for Sjögren’s syndrome - ACR Convergence Today - 1 year(s) ago
Experts including Alen Zabotti, MD, reviewed a variety of methods to identify, prevent, and manage Sjögren’s syndrome. Dr. Zabotti discussed the assessment of glandular involvement in primary Sjögren’s syndrome through biopsy and imaging.
Source: ACR Convergence TodayCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Proposed classification criteria for pediatric CNO and CRMO explained - ACR Convergence Today - 1 year(s) ago
Recently developed classification criteria for pediatric chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO) await ACR and EULAR endorsement. Yongdong “Dan” Zhao, MD, PhD, RhMSUS, explained how point values are assigned for each of the 10 criteria.
Source: ACR Convergence TodayCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Stats Bootcamp III explores applications of multi-dimensional omics data - ACR Convergence Today - 1 year(s) ago
Onyinye Iweala, MD, PhD, outlined bulk transcriptomics profiling and methods focused on characterizing individual cells. She explained that handling vast quantities of multidimensional data requires specialized statistical and data visualization.
Source: ACR Convergence TodayCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Experts look at bacterial infections and their relationship to autoimmune diseases - ACR Convergence Today - 1 year(s) ago
Panelist Madeleine Cunningham, PhD, highlighted the connection between streptococcal infection, autoimmunity, and molecular mimicry. She reviewed how antigenic determinants are shared between the host and invading organism.
Source: ACR Convergence TodayCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1Trans-omic technologies bring new insights into immune-mediated disease pathology - ACR Convergence Today - 1 year(s) ago
In a joint session of the ACR and the Japan College of Rheumatology, experts including Keishi Fujio, MD, PhD, discussed recent advances in omic technology that pave the way for novel approaches to the translation of basic science discoveries into clinical rheumatology.
Source: ACR Convergence TodayCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
In 2022, the U.S. Food and Drug Administration approved the use of new agents for pediatric lupus nephritis, juvenile psoriatic arthritis, and enthesitis-related arthritis. Amit Golding, MD, PhD, highlighted the approvals of belimumab IV, ustekinumab, and secukinumab, and Cmdr. Hyun Son, PharmD, discussed the FDA’s role when drug shortages occur.
Source: ACR Convergence TodayCategories: Latest Headlines, RheumatologyTweet
#ACR22 Recap: ACR Workforce Solutions Committee members outlined the impact of physician shortages & explored potential interventions → https://t.co/TcgLVuURbu https://t.co/KGtofqU9Cy